Trial Identifier: | D5670C00025 |
Sponsor: | MedImmune, LLC |
NCTID:: | NCT04091373 |
Start Date: | September 2019 |
Primary Completion Date: | March 2020 |
Study Completion Date: | March 2020 |
Condition: | Diabetes: Type 2 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English version |
Country | Location |
---|---|
United States of America, FL | Daytona Beach, FL, United States of America, 32117 |